Mark Rijpkema

Combined quantitative dynamic contrast‐enhanced MR imaging and ¹H MR spectroscopic imaging of human prostate cancer

Ferdinand A. van Dorsten, Marinette van der Graaf, Marc Engelbrecht et al. · Journal of Magnetic Resonance Imaging · 2004 · 162 citations

Tumor-targeted Dual-modality Imaging to Improve Intraoperative Visualization of Clear Cell Renal Cell Carcinoma: A First in Man Study

Marlène C.H. Hekman, Mark Rijpkema, Egbert Oosterwijk et al. · Theranostics · 2018 · 121 citations · Full text

Effects of breathing a hyperoxic hypercapnic gas mixture on blood oxygenation and vascularity of head-and-neck tumors as measured by magnetic resonance imaging

Mark Rijpkema, Johannes H.A.M. Kaanders, F.B.M. Joosten et al. · International Journal of Radiation Oncology*Biology*Physics · 2002 · 116 citations

Neuro-oncology, Blood Oxygenation, Hypoxia (Medicine) +10

Prediction of chemotherapeutic response of colorectal liver metastases with dynamic gadolinium‐DTPA‐enhanced MRI and localized ¹⁹F MRS pharmacokinetic studies of 5‐fluorouracil

Hanneke W.M. van Laarhoven, Dennis W. J. Klomp, Mark Rijpkema et al. · NMR in Biomedicine · 2006 · 52 citations

Method for quantitation of dynamic MRI contrast agent uptake in colorectal liver metastases

Hanneke W.M. van Laarhoven, Mark Rijpkema, Cornelis J.A. Punt et al. · Journal of Magnetic Resonance Imaging · 2003 · 47 citations · Full text